GlaxoSmithKline has poached Merck KGaA's Maya Martinez-Davis to head up its US Pharmaceuticals division as it announces current president Jack Bailey will be stepping down at the end of the
GlaxoSmithKline has forged an alliance with two leading CRISPR researchers that will see the creation of a new genomics research lab at the University of California.
Novartis has positive data for a two-drug asthma regimen that forms the backbone of its efforts to take on rival GlaxoSmithKline in the respiratory market.
GlaxoSmithKline CEO Emma Walmsley has been predicting big things for respiratory triple therapy Trelegy in the next couple of years and has new data that could open up a new market.